Inhibition of EZH2 upregulated the inflammatory genes (TNF-α and TGF-β) and specific miRs (miR-200b and miR-155) and subsequently favored hepatic steatosis in NAFLD [83]. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.